CSL Signs Agreement to Manufacture & Supply COVID-19 Vaccine | ASX Market Update

September 07, 2020 02:12 AM PDT | By Team Kalkine Media

Google News:

Recent News

Kroger (NYSE:KR) Shows Steady Performance Amidst S&P 500

Cummins Inc (NYSE:CMI) Stock Gains Attention Russell 1000

Wingstop (NASDAQ:WING) Stock Performance Nasdaq Composite

Estimating Intrinsic Value Of Analog Devices (NASDAQ:ADI) Stock S&P 50...

PointsBet Holdings Limited (ASX:PBH) announced the commencement of the institutional component of its 1 for 6.5 accelerated pro-rata renounceable entitlement offer to raise A$153.2 million by issuing each new share at A$6.50. The Retail Entitlement Offer component of the Entitlement Offer is anticipated to open on 11 September 2020 and close on 22 September 2020. Retail rights trading shall be available from 9 September 2020 till 15 September 2020.

Viva Energy Group Limited (ASX:VEA) provided a trading update amid easing of restrictions in Victoria on 6 September and the impact of coronavirus. Below are some of the highlights: Retail business continues to be resilient even after on-going restrictions in Victoria and sales is recovering in other states and territories. Commercial business excluding Aviation in Victoria also stays relatively unaltered by the present restrictions. Refining business continues to be affected by COVID-19 and the outlook stays challenging due to drop in the demand for oil products globally which are mulling over regional refining margins.

ASX 200 listed biotech major, CSL Limited (ASX:CSL) signed two agreements to manufacture and supply COVID-19 vaccines V451 and AZD1222, subject to clinical trials of both proving successful. Heads of agreement (HoA) with the Government of Australia to supply nearly 51 million doses of the University of Queensland’s COVID-19 vaccine candidate (V451). Another HoA with AstraZeneca to manufacture COVID-19 vaccine candidate of the Oxford University (AZD1222).

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.